157 related articles for article (PubMed ID: 24615112)
21. Combined effects of collagen type I alpha1 (COL1A1) Sp1 polymorphism and osteoporosis risk factors on bone mineral density in Turkish postmenopausal women.
Kurt-Sirin O; Yilmaz-Aydogan H; Uyar M; Seyhan MF; Isbir T; Can A
Gene; 2014 May; 540(2):226-31. PubMed ID: 24566004
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of common variants in CNR2 gene for bone mineral density and osteoporosis susceptibility in postmenopausal women of Han Chinese.
Zhang C; Ma J; Chen G; Fu D; Li L; Li M
Osteoporos Int; 2015 Dec; 26(12):2803-10. PubMed ID: 26055357
[TBL] [Abstract][Full Text] [Related]
23. [Osteoprotegerin gene polymorphism and therapeutic response to alendronate in postmenopausal women with osteoporosis].
Wang C; He JW; Qin YJ; Zhang H; Hu WW; Liu YJ; Zhang ZL
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2958-62. PubMed ID: 20137703
[TBL] [Abstract][Full Text] [Related]
24. [Polymorphism of osteoprotegerin gene and osteoporosis in postmenopausal women].
Seremak-Mrozikiewicz A; Tatuśko J; Drews K; Barlik M; Krajewski P; Spaczyński M; Mrozikiewicz PM
Ginekol Pol; 2009 May; 80(5):354-60. PubMed ID: 19548455
[TBL] [Abstract][Full Text] [Related]
25. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
[TBL] [Abstract][Full Text] [Related]
26. OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia.
Zheng H; Wang C; He JW; Fu WZ; Zhang ZL
Pharmacogenet Genomics; 2016 Jan; 26(1):12-9. PubMed ID: 26426211
[TBL] [Abstract][Full Text] [Related]
27. Impact of genetic variants of IL-6, IL6R, LRP5, ESR1 and SP7 genes on bone mineral density in postmenopausal Mexican-Mestizo women with obesity.
Méndez JP; Rojano-Mejía D; Coral-Vázquez RM; Coronel A; Pedraza J; Casas MJ; Soriano R; García-García E; Vilchis F; Canto P
Gene; 2013 Oct; 528(2):216-20. PubMed ID: 23891823
[TBL] [Abstract][Full Text] [Related]
28. Genetic profiling of decreased bone mineral density in an independent sample of Caucasian women.
Xiao X; Roohani D; Wu Q
Osteoporos Int; 2018 Aug; 29(8):1807-1814. PubMed ID: 29713799
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in genes in the RANKL/RANK/OPG pathway are associated with bone mineral density at different skeletal sites in post-menopausal women.
Tu P; Duan P; Zhang RS; Xu DB; Wang Y; Wu HP; Liu YH; Si L
Osteoporos Int; 2015 Jan; 26(1):179-85. PubMed ID: 25138264
[TBL] [Abstract][Full Text] [Related]
30. Relation of JAGGED 1 and collagen type 1 alpha 1 polymorphisms with bone mineral density in Chinese postmenopausal women.
Zhang LQ; Liu H; Huang XF
Int J Clin Exp Pathol; 2014; 7(10):7142-7. PubMed ID: 25400810
[TBL] [Abstract][Full Text] [Related]
31. TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women.
Rojano-Mejía D; Coral-Vázquez RM; Espinosa LC; Romero-Hidalgo S; López-Medina G; García Mdel C; Coronel A; Ibarra R; Canto P
Maturitas; 2012 Jan; 71(1):49-54. PubMed ID: 22079369
[TBL] [Abstract][Full Text] [Related]
32. Association of estrogen receptor alpha and collagen type I alpha 1 gene polymorphisms with bone mineral density in postmenopausal women.
Erdogan MO; Yıldız H; Artan S; Solak M; Taşcıoğlu F; Dündar U; Eser B; Colak E
Osteoporos Int; 2011 Apr; 22(4):1219-25. PubMed ID: 20532479
[TBL] [Abstract][Full Text] [Related]
33. A polymorphism rs6815464 in the macrophage erythroblast attacher gene is associated with low bone mineral density in postmenopausal Japanese women.
Che Y; Sugita N; Yoshihara A; Iwasaki M; Miyazaki H; Nakamura K; Yoshie H
Gene; 2019 Jun; 700():1-6. PubMed ID: 30890479
[TBL] [Abstract][Full Text] [Related]
34. TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.
Mencej-Bedrač S; Preželj J; Marc J
Maturitas; 2011 Jul; 69(3):263-7. PubMed ID: 21411255
[TBL] [Abstract][Full Text] [Related]
35. Association of VDR and OPG gene polymorphism with osteoporosis risk in Chinese postmenopausal women.
Wu F; Zhou D; Shen G; Cui Y; Lv Q; Wei F
Climacteric; 2019 Apr; 22(2):208-212. PubMed ID: 30624097
[TBL] [Abstract][Full Text] [Related]
36. Relation of BsmI vitamin D receptor gene polymorphism to bone mineral density and occurrence of osteoporosis in postmenopausal Chinese women in Taiwan.
Chen HY; Chen WC; Hsu CD; Tsai FJ; Tsai CH; Li CW
Osteoporos Int; 2001 Dec; 12(12):1036-41. PubMed ID: 11846330
[TBL] [Abstract][Full Text] [Related]
37. The influence of vitamin D receptor genetic variants on bone mineral density and osteoporosis in Chinese postmenopausal women.
He W; Liu M; Huang X; Qing Z; Gao W
Dis Markers; 2015; 2015():760313. PubMed ID: 25784778
[TBL] [Abstract][Full Text] [Related]
38. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.
Arko B; Prezelj J; Kocijancic A; Komel R; Marc J
Maturitas; 2005 Jul; 51(3):270-9. PubMed ID: 15978970
[TBL] [Abstract][Full Text] [Related]
39. The ALUI calcitonin receptor gene polymorphism (TT) is associated with low bone mineral density and susceptibility to osteoporosis in postmenopausal women.
Tsai FJ; Chen WC; Chen HY; Tsai CH
Gynecol Obstet Invest; 2003; 55(2):82-7. PubMed ID: 12771454
[TBL] [Abstract][Full Text] [Related]
40. Association of vitamin D receptor gene polymorphism (TaqI and Apa1) with bone mineral density in North Indian postmenopausal women.
Ahmad I; Jafar T; Mahdi F; Ameta K; Arshad M; Das SK; Waliullah S; Rizvi I; Mahdi AA
Gene; 2018 Jun; 659():123-127. PubMed ID: 29559350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
